MedPath

The MIND-GUT Digital Pilot Intervention Study

Not Applicable
Not yet recruiting
Conditions
Depressive Symptoms
Anxiety
Stress
Obesity
Dysbiosis
Eating Habit
Interventions
Behavioral: Dietary intervention based on the MIND diet
Registration Number
NCT06374407
Lead Sponsor
University of Skövde
Brief Summary

This 12-week pilot study aims to evaluate the feasibility and effectiveness of a dietary intervention targeting diet, obesity, mental health, and the gut microbiome in promoting weight loss and enhancing mental health among obese men and women aged 30-50. Participants, excluding those with specific medical conditions, will be randomly assigned to either an intervention or control group using a meal planning smartphone app. Clinical assessments will include anthropometry, mental health questionnaires, dietary recalls, and stool sample collections. The study's endpoints include program retention, adherence, changes in body weight, mental health, and gut microbiome diversity. Statistical analyses will evaluate intervention effects and the potential mediating roles of the gut microbiome. This pilot study has implications for health policies, public healthcare, digital health companies, and the biotech and pharmacology industries. Future plans involve a large-scale intervention study in multiple countries with ongoing collaborations.

Detailed Description

Objective of the Pilot Study and Study Design:

This 12-week randomized pilot intervention study aims to assess the feasibility and effectiveness of a dietary intervention targeting diet, obesity, mental health, and the gut microbiome in promoting weight loss and enhancing mental health among obese individuals aged 30-50.

Participant Recruitment and Randomization:

Participants aged 30-50, excluding those with specific medical conditions such as psychiatric medication use, food allergies affecting diets, eating disorders, diabetes, polycystic ovary syndrome, sensory deficits, recent antibiotic use, participation in other studies, language limitations, coeliac/inflammatory bowel disease, planned weight management within 3 months, and pregnant/lactating/post-menopausal women, will be recruited for the study. Randomization will be conducted to assign eligible participants to either an intervention or control group using a meal planning smartphone app.

Clinical Assessments:

Clinical assessments will include anthropometry, mental health questionnaires, dietary recalls, and stool sample collections.

Study Endpoints:

The study's endpoints include program retention, adherence, changes in body weight, mental health, and gut microbiome diversity.

Statistical Analyses:

Statistical analyses will evaluate the study feasibility, intervention effects on body weight and mental health changes, and the potential mediating roles of these effects by the gut microbiome.

Implications and Future Plans:

This pilot study has implications for health policies, public healthcare, digital health companies, and the biotech and pharmacology industries. Future plans involve a large-scale intervention study in multiple countries with ongoing collaborations.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
126
Inclusion Criteria
  • age 30- 50;
  • BMI ≥ 30 kg/m2;
  • stable physical activity;
  • one person per household;
  • commitment to full protocol.
Exclusion Criteria
  • use of psychiatric medications (e.g., serotonin reuptake inhibitors);
  • use of weight loss medications (GLP-1 receptor agonists);
  • food allergies affecting adherence to the MIND diet;
  • diagnosis of eating disorders;
  • diagnosis of diabetes;
  • diagnosis of polycystic ovary syndrome;
  • sensory deficits (e.g., COVID-19-induced loss of taste/smell);
  • antibiotic use during the latest 3 months;
  • participation in another study;
  • language understanding limitations (i.e., not able to understand either Swedish or English); - coeliac/inflammatory bowel disease;
  • planned weight management program within three months;
  • pregnancy;
  • lactation;
  • menopause.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupDietary intervention based on the MIND dietThe control group comprises participants who do not receive the specific Mind diet intervention but undergo the same procedures as the intervention group, including weighing at the beginning and end of the study, completing identical questionnaires, and providing fecal samples at recruitment and follow-up. They will also use the same meal-planning app as the intervention group.
Intervention groupDietary intervention based on the MIND dietThe intervention group consists of participants who receive the Mind diet intervention. Like the control group, they will be weighed at the start and end of the study, answer the same questionnaires, and provide fecal samples at recruitment and follow-up. Additionally, they will use the same meal-planning app as the control group, but their dietary pattern will be based on the Mind diet.
Primary Outcome Measures
NameTimeMethod
Study effectiveness: change in depression symptoms at follow-up12 weeks

Comparison of PHQ-9 questionnaire at baseline vs. follow-up. The PHQ-9 is a tool to assist clinicians in identifying and diagnosing major depression. It has a maximum score of 27. Higher scores correspond to worst outcomes in terms of depression symtoms.

Study effectiveness: change in body weight at follow-up12 weeks

Comparison of body weight at baseline vs. follow-up

Study effectiveness: change in % total fat mass at follow-up12 weeks

Comparison of body % total fat mass at baseline vs. follow-up

Acceptability12 weeks

Assessment of participants' experience of the program through qualitative interviews, focusing in particular on: Perception of and experience with the intervention, intervention components (dietary plans, use of the app, etc.), factors influencing participants' engagement, perceived impact on behavior and well-being, interaction with the staff, suggestions for improvement.

Study effectiveness: change in eating attitudes at follow-up12 weeks

Comparison of a score calculated after administration of the EAT-26 questionnaire at baseline vs. follow-up. The EAT-26 comprises three subscales, namely, Dieting, Bulimia and Food Preoccupation, and Oral Control. Higher scores correspond to a worse outcome.

Study effectiveness: change in anxiety symtoms at follow-up12 weeks

Comparison of GAD-7 questionnaire at baseline vs. follow-up. Each item is scored on a four-point Likert scale (0-3) with total scores ranging from 0 to 21 with higher scores reflecting worst outcomes in terms of anxiety severity.

Study effectiveness: change in % visceral fat mass at follow-up12 weeks

Comparison of body % visceral fat at baseline vs. follow-up

Study effectiveness: change in microbiome variety at follow-up12 weeks

Comparison of number and types of species at baseline vs. follow-up.

Program retention12 weeks

Evaluation of participants' continued engagement in the program over time i.e., % of individuals completing the second and third 24h diet recall and % of participants returning to the second visit at the end of the intervention.

Study effectiveness: change in waist circumference at follow-up12 weeks

Comparison of waist circumference at baseline vs. follow-up

Study effectiveness: change in hip circumference at follow-up12 weeks

Comparison of hip circumference at baseline vs. follow-up

Adherence12 weeks

Measurement of participants' compliance with the assigned diet and program through 24h recall interviews, assessed comparing reported intake frequencies of each food group with the recommended intake frequencies according to the principles of the MIND diet.

Study effectiveness: change in stress levels at follow-up12 weeks

Comparison of PSS-4 questionnaire at baseline vs. follow-up. The PSS total score is calculated by reverse-coding the positive items and summing the scores for all items. The total scores range from 0 to 56, from 0 to 40, and from 0 to 16 for the PSS-14, PSS-10, and PSS-4, respectively. A higher score indicates more perceived stress.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Skövde

🇸🇪

Skövde, Sweden

© Copyright 2025. All Rights Reserved by MedPath